Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging. - Wikidata - wikimedia - TriplyDB

Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.

Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.

http://www.wikidata.org/entity/Q37114306

about

Effects of Rosuvastatin Alone or in Combination with Omega-3 Fatty Acid on Adiponectin Levels and Cardiometabolic Profile Potential Neuroprotective Effects of Adiponectin in Alzheimer's Disease.Adiponectin Receptors Are Less Sensitive to Stress in a Transgenic Mouse Model of Alzheimer's Disease.Importance of adiponectin activity in the pathogenesis of Alzheimer's disease.Association between Fetal Adipokines and Child Behavioral Problems at Preschool Age: The Hokkaido Study on Environment and Children's Health.

P2860

Q28468474-387E1563-AEDF-49A8-9022-2D34C827CB8D Q37729219-DA19E709-40DA-4437-BC2B-22C0DBF9812E Q37746842-24C795CD-2541-4A41-AD1F-7E7198E2DCB6 Q41357850-AC025C9A-806D-4330-8BA0-E11B753AFE95 Q47556870-AEB8A871-D1D4-4E9A-A9E8-5BEB977836E6

P2860

Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.

http://www.wikidata.org/entity/Q37114306

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.

@en

Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.

@nl

type

label

Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.

@en

Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.

@nl

prefLabel

Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.

@en

Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.

@nl

P1433

Q37114306-CD2EA7D5-E909-4E7F-BFE2-37DA81A82F71

P1476

Q37114306-29BD898B-60F2-4A29-BE77-52CC2425A4D4

P2093

Q37114306-73203861-AF16-46E4-AE9A-844E4FF8EF6D

Q37114306-739B3E18-2626-4B1A-981C-D7E47647E393

Q37114306-8C20B80E-C23C-4897-9306-FA1546F5391C

Q37114306-91C7E9C5-E93C-415D-8DDD-B5C476D0C369

Q37114306-CD9D301E-8CFF-4308-8C82-5D666E03FEF2

P2860

Q37114306-00E74C70-F1C1-41DF-A0E3-4D1C0DF4C5A7

Q37114306-0DCC7598-F6E3-45F9-B546-B6C1A7DFB082

Q37114306-1229B7AE-E2A5-4AAC-9B84-828578F72F35

Q37114306-14ECB57A-C64B-47AB-A905-A87293AE22B9

Q37114306-1594FEB7-377B-4E2F-BC29-00B649378BCE

Q37114306-1955891C-0329-44C7-B14A-F56150470EC0

Q37114306-214EEA23-49EE-4DFD-A889-153D1961443B

Q37114306-23B85027-6BBC-475C-8736-39E230FDD7D2

Q37114306-28748DC2-39FB-4C15-B711-50FF84D3FA30

Q37114306-42A15781-05C7-4D21-A320-23B746525D70

P304

Q37114306-D0E70976-DA5E-4850-A08C-938A3F0285F4

P31

Q37114306-908ADBB2-C2AC-42DF-8C14-0863C98BB984

P356

Q37114306-89D47B43-5CF5-4CE6-AA98-9AF9521DB15E

P433

Q37114306-F387A9A5-22B2-450C-82BA-80D7C9FB9D4E

P478

Q37114306-E84C4AB1-15BB-4904-BE5D-F75BB4354B0A

P50

Q37114306-01C8B18A-B734-49D0-9EA1-A298723256DD

Q37114306-747AE437-D00F-4676-B081-EBD29CCE370A

Q37114306-A31BCB81-9931-4451-A949-694FAF569B36

P577

Q37114306-BFC2CA3F-C76F-4FD2-A8A5-7036C528E783

P698

Q37114306-92900E2B-4A88-48AA-80B7-4125781168D3

P921

Q37114306-601CAD49-BD10-4E22-BDD2-A0D68F6CAB75

P932

Q37114306-32AB06F0-0B94-4402-B19C-567088E35119

P356

P1433

Journal of Alzheimer's Disease

P1476

Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.

@en

P2093

Alexandra M V Wennberg

http://www.w3.org/2001/XMLSchema#string

Clinton E Hagen

http://www.w3.org/2001/XMLSchema#string

Deborah Gustafson

http://www.w3.org/2001/XMLSchema#string

Michelle M Mielke

http://www.w3.org/2001/XMLSchema#string

Rosebud O Roberts

http://www.w3.org/2001/XMLSchema#string

P2860

Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages

Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies

Aberrant insulin signaling in Alzheimer's disease: current knowledge

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

The Clinical Dementia Rating (CDR): current version and scoring rules

An inventory for measuring clinical anxiety: psychometric properties

The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.

Comparison of 18F-FDG and PiB PET in cognitive impairment.

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

Energy expenditure in Alzheimer's disease.

P304

573-581

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-151201

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Ronald C. Petersen

David S Knopman

P577

2016-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27163809

http://www.w3.org/2001/XMLSchema#string

P921

P932

4955718

http://www.w3.org/2001/XMLSchema#string